AdvanSix (ASIX) versus The Competition Financial Comparison
AdvanSix (NYSE: ASIX) is one of 47 public companies in the “Specialty Chemicals” industry, but how does it weigh in compared to its rivals? We will compare AdvanSix to related companies based on the strength of its risk, analyst recommendations, earnings, profitability, institutional ownership, dividends and valuation.
This table compares AdvanSix and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a breakdown of recent ratings and recommmendations for AdvanSix and its rivals, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
AdvanSix currently has a consensus target price of $46.00, indicating a potential upside of 13.19%. As a group, “Specialty Chemicals” companies have a potential downside of 0.04%. Given AdvanSix’s stronger consensus rating and higher possible upside, equities analysts clearly believe AdvanSix is more favorable than its rivals.
Insider & Institutional Ownership
71.4% of AdvanSix shares are held by institutional investors. Comparatively, 65.3% of shares of all “Specialty Chemicals” companies are held by institutional investors. 2.7% of AdvanSix shares are held by insiders. Comparatively, 7.4% of shares of all “Specialty Chemicals” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Volatility & Risk
AdvanSix has a beta of 2.84, indicating that its stock price is 184% more volatile than the S&P 500. Comparatively, AdvanSix’s rivals have a beta of 1.37, indicating that their average stock price is 37% more volatile than the S&P 500.
Earnings and Valuation
This table compares AdvanSix and its rivals top-line revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|AdvanSix||$1.19 billion||$34.14 million||25.72|
|AdvanSix Competitors||$1.91 billion||$115.75 million||228.77|
AdvanSix’s rivals have higher revenue and earnings than AdvanSix. AdvanSix is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
AdvanSix beats its rivals on 8 of the 13 factors compared.
AdvanSix Inc. is an integrated manufacturer of Nylon 6. The Company also sells a variety of other products, all of which are produced as part of the Nylon 6 resin manufacturing process primarily, including caprolactam, ammonium sulfate fertilizers and other chemical intermediates. The Company operates primarily through its integrated manufacturing sites located in Frankford, Pennsylvania, Hopewell, Virginia, and Chesterfield, Virginia. The Company offers ammonium sulfate, which is used by customers as a nitrogen-based fertilizer. It produces ammonium sulfate fertilizer as part of its manufacturing process. The Company manufactures ammonium sulfate fertilizers including Sulf-N and Sulf-N 26. The Company provides AdvanSix Aegis nylon resins and Aegis barrier nylon resins. Its nylon resins are a preferred choice in food, liquid, and consumer packaging along with mono/multifilament products, carpet fibers, automotive compounding and more. It offers Capran biaxially oriented nylon films.
Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.